Skip to main content
SpringerLink
Log in

Assessment of MGMT promoter methylation status in pleomorphic xanthoastrocytoma

  • Clinical Study - Patient Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Although pleomorphic xanthoastrocytoma (PXA) is currently designed as a grade II glioma according to the WHO classification, a significant percentage of the tumors undergo malignant progression. In this study, the MGMT methylation status was examined in 11 PXA patients to determine if a biologic rationale exists to support the use of temozolomide (TMZ) for treatment of aggressive PXA. There were 9 cases of PXA grade II and 2 cases of PXA with anaplastic features. In the MGMT methylation study, only 2 (18.1%) of the 11 tumor samples tested by MS-qLNAPCR were positive for MGMT promoter methylation. In contrast, other cases, including PXAs with anaplastic features, were unmethylated. In addition, a tumor recurrence was found to be unmethylated. Thus, MGMT promoter methylation is not frequent in PXA and our results raise doubts about the benefits of treating indistinctly aggressive PXA with TMZ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) World Health Organization classification of tumours of the central nervous system. IARC Press, Lyon

    Google Scholar 

  2. Giannini C, Scheithauer BW, Burger PC et al (1999) Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer 85:2033–2045

    PubMed  CAS  Google Scholar 

  3. Pahapill PA, Ramsay DA, Del Maestro RF (1996) Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis. Neurosurgery 38:822–828

    Article  PubMed  CAS  Google Scholar 

  4. Alexiou GA, Moschovi M, Stefanaki K, Prodromou C, Sfakianos G, Prodromou N (2010) Malignant progression of a pleomorphic xanthoastrocytoma in a child. Neuropediatrics 41:69–71

    Article  PubMed  CAS  Google Scholar 

  5. Tsutsumi S, Abe Y, Yasumoto Y, Ito M (2010) Anaplastic pleomorphic xanthoastrocytoma with a component of anaplastic astrocytoma presenting as skull base tumor followed by downward extracranial extension. Neurol Med Chir 50:1108–1112

    Article  Google Scholar 

  6. Hegi ME, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003

    Article  PubMed  CAS  Google Scholar 

  7. Morandi L, Franceschi E, de Biase D et al (2010) Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference. BMC Cancer 10:48

    Article  PubMed  CAS  Google Scholar 

  8. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods 25:402–408

    Article  PubMed  CAS  Google Scholar 

  9. Houillier C, Wang X, Kaloshi G et al (2010) IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. Neurology 75:1560–1566

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Section of Pathology, Department of Haematology and Oncology “L. and A. Seragnoli”, University of Bologna, Bellaria Hospital, Via Altura 3, 40139, Bologna, Italy

    Gianluca Marucci

  2. Section of Pathology, Department of Haematology and Oncology “L. and A. Seragnoli”, University of Bologna, Bellaria Hospital, Bologna, Italy

    Luca Morandi

Authors
  1. Gianluca Marucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luca Morandi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gianluca Marucci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marucci, G., Morandi, L. Assessment of MGMT promoter methylation status in pleomorphic xanthoastrocytoma. J Neurooncol 105, 397–400 (2011). https://doi.org/10.1007/s11060-011-0605-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-011-0605-6

Keywords

Search

Navigation